CVC Capital is to sell women’s health-focused pharmaceutical company Theramex to PAI and Carlyle; the SBO is valued at GBP 1.2bn, according to two sources familiar with the situation.
CVC Capital is to sell women’s health-focused pharmaceutical company Theramex to PAI and Carlyle; the SBO is valued at GBP 1.2bn, according to two sources familiar with the situation.